{"id":50753,"date":"2023-09-20T09:12:31","date_gmt":"2023-09-20T09:12:31","guid":{"rendered":"https:\/\/medsname.com\/pioglit-mf-forte\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"pioglit-mf-forte","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/pioglit-mf-forte\/","title":{"rendered":"Pioglit Mf Forte"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Pioglit MF Forte?<\/h3>\n<p style=\"margin:0;\"><strong>Pioglit MF Forte<\/strong> is a fixed-dose combination tablet of <strong>pioglitazone (15 mg)<\/strong> \u03ba\u03b1\u03b9 <strong>metformin (850 mg)<\/strong> \u03b3\u03b9\u03b1 <strong>type&nbsp;2 diabetes<\/strong>. It pairs two insulin-sensitising mechanisms: metformin cuts hepatic glucose production, and pioglitazone activates PPAR-&gamma; to reduce peripheral insulin resistance. Expected HbA1c fall: <strong>1.5&ndash;2.0 points<\/strong>. <strong>No hypoglycaemia<\/strong> when used alone (neither component stimulates insulin release). Typical dose: one tablet twice daily with meals. Main trade-offs: weight gain (2&ndash;4 kg), fluid retention and oedema, and the usual metformin GI upset in the first two weeks. Avoid in heart failure, eGFR &lt; 30, active bladder cancer, and severe hepatic impairment.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>\u0391\u03c5\u03c4\u03cc \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd MedsBase:<\/strong> \u03a0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae\u03c2 WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 <a href=\"https:\/\/medsbase.com\/el\/reviews\/\">\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>\u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n<h2 class=\"wp-block-heading\">What Is Pioglit MF Forte?<\/h2>\n<p>Pioglit MF Forte is a fixed-dose combination oral antidiabetic tablet containing <strong>pioglitazone (15 mg)<\/strong> \u03ba\u03b1\u03b9 <strong>metformin hydrochloride (850 mg)<\/strong>, manufactured by Sun Pharma. Available in packs of 30, 60, 90 or 180 tablets. It is used in adults with type&nbsp;2 diabetes when single-agent metformin is not sufficient and insulin resistance is thought to be a major driver of hyperglycaemia.<\/p>\n<h2 class=\"wp-block-heading\">How Does Pioglit MF Forte Work?<\/h2>\n<p>Pioglit MF Forte pairs two complementary mechanisms that both target insulin resistance without stimulating insulin release:<\/p>\n<ul>\n<li><strong>\u039c\u03b5\u03c4\u03c6\u03bf\u03c1\u03bc\u03af\u03bd\u03b7<\/strong> &mdash; activates AMPK in the liver, cutting hepatic gluconeogenesis by roughly one third. It also improves peripheral insulin sensitivity and modestly slows intestinal glucose absorption.<\/li>\n<li><strong>Pioglitazone<\/strong> &mdash; a PPAR-&gamma; agonist that improves insulin sensitivity in muscle and fat, shifts fat storage from visceral to subcutaneous depots, and improves hepatic steatosis.<\/li>\n<\/ul>\n<p>Because neither drug stimulates insulin release, the combination <strong>does not cause hypoglycaemia<\/strong> on its own. HbA1c reduction is typically <strong>1.5&ndash;2.0 percentage points<\/strong>. Pioglitazone also improves HDL and triglycerides and may benefit non-alcoholic fatty liver disease.<\/p>\n<h2 class=\"wp-block-heading\">\u0394\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n<p><strong>Usual dose:<\/strong> one tablet once or twice daily with food. The starting dose is chosen to match the patient&rsquo;s current therapy; titrate upward every 4&ndash;8 weeks based on HbA1c and tolerability. Maximum daily dose: pioglitazone 45&nbsp;mg + metformin 2,000&nbsp;mg.<\/p>\n<ul>\n<li><strong>Take with food<\/strong> &mdash; reduces metformin GI upset.<\/li>\n<li><strong>Allow 8&ndash;12 weeks<\/strong> before judging the pioglitazone component &mdash; it is slow-onset.<\/li>\n<li><strong>Renal dosing.<\/strong> Avoid if eGFR &lt; 30. Halve metformin if eGFR 30&ndash;45.<\/li>\n<li><strong>Hold for IV contrast, surgery, or acute illness<\/strong> with dehydration.<\/li>\n<li>Monitor weight, ankle oedema, ALT, and vitamin B12 periodically.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n<p><strong>From metformin (first 1&ndash;2 weeks):<\/strong> diarrhoea, nausea, abdominal cramps, metallic taste, flatulence. Usually improve with time or SR formulation.<\/p>\n<p><strong>From pioglitazone:<\/strong><\/p>\n<ul>\n<li>Weight gain (2&ndash;4 kg)<\/li>\n<li>Peripheral oedema &mdash; most common reason for stopping<\/li>\n<li>Mild anaemia (haemodilution)<\/li>\n<li>Headache, myalgia, upper respiratory infection<\/li>\n<li>Rare: heart failure decompensation, bladder cancer signal (long-term high-dose), macular oedema, bone fracture (women)<\/li>\n<\/ul>\n<p><strong>Rare but serious (metformin):<\/strong> lactic acidosis &mdash; almost always in the setting of AKI, sepsis, or hypoxia. Vitamin B12 deficiency with long-term use; check annually.<\/p>\n<h2 class=\"wp-block-heading\">\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n<ul>\n<li><strong>Gemfibrozil<\/strong> &mdash; doubles pioglitazone levels; limit pioglitazone to 15&nbsp;mg\/day.<\/li>\n<li><strong>Rifampicin<\/strong> &mdash; reduces pioglitazone levels.<\/li>\n<li><strong>IV iodinated contrast<\/strong> &mdash; hold metformin (48 hours post-procedure if eGFR &lt; 60).<\/li>\n<li><strong>Insulin<\/strong> &mdash; additive fluid retention; be alert for oedema and heart failure.<\/li>\n<li><strong>Sulfonylureas \/ meglitinides \/ insulin<\/strong> &mdash; add hypoglycaemia risk (absent on Pioglit MF Forte alone).<\/li>\n<li><strong>Cationic drugs<\/strong> (cimetidine, dolutegravir, ranolazine) &mdash; raise metformin levels.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Who Should Not Take Pioglit MF Forte?<\/h2>\n<ul>\n<li>Heart failure (NYHA III&ndash;IV)<\/li>\n<li>Active bladder cancer or previous bladder cancer<\/li>\n<li>Unexplained macroscopic haematuria<\/li>\n<li>Severe renal impairment (eGFR &lt; 30)<\/li>\n<li>Severe hepatic impairment or ALT &gt; 2.5&times; upper limit of normal<\/li>\n<li>Diabetic ketoacidosis; type&nbsp;1 diabetes<\/li>\n<li>Acute illness with risk of tissue hypoxia<\/li>\n<li>Pregnancy, breastfeeding<\/li>\n<li>Known hypersensitivity to either component<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n<p>Store Pioglit MF Forte below 30&deg;C in a dry place. Keep out of reach of children.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3 class=\"wp-block-heading\">Is Pioglit MF Forte the same as taking metformin and pioglitazone separately?<\/h3>\n<p>Clinically, yes &mdash; same molecules, same doses. The fixed-dose combination simplifies the regimen (one tablet instead of two), typically improves adherence, and is usually less expensive than the two components bought separately.<\/p>\n<h3 class=\"wp-block-heading\">Will Pioglit MF Forte cause hypoglycaemia?<\/h3>\n<p>Not on its own &mdash; neither metformin nor pioglitazone stimulates insulin release. Hypoglycaemia only becomes a concern when Pioglit MF Forte is combined with a sulfonylurea, meglitinide, or insulin.<\/p>\n<h3 class=\"wp-block-heading\">Does Pioglit MF Forte cause weight gain?<\/h3>\n<p>Pioglitazone causes 2&ndash;4 kg weight gain, partly offset by metformin&rsquo;s weight-neutral or slightly weight-reducing effect. Net change is usually 1&ndash;3 kg gained over the first year.<\/p>\n<h3 class=\"wp-black-heading\">Can I take Pioglit MF Forte if I have fatty liver or NASH?<\/h3>\n<p>Yes &mdash; pioglitazone is one of the few drugs with good evidence in non-alcoholic steatohepatitis (PIVENS trial showed histological improvement). Metformin has more limited NASH-specific evidence but is weight-favourable and reduces hepatic glucose output.<\/p>\n<h3 class=\"wp-block-heading\">What if I have mild fluid retention?<\/h3>\n<p>Mild ankle swelling can sometimes be managed with dose reduction or adding a diuretic. Breathlessness, rapid weight gain, or new peripheral oedema warrants prompt medical review &mdash; pioglitazone may need stopping.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol while taking Pioglit MF Forte?<\/h3>\n<p>Moderate alcohol with food is usually safe. Avoid binge drinking &mdash; it raises lactic acidosis risk (metformin) and can impair liver function (both drugs).<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Pioglit MF Forte online?<\/h3>\n<p>You can order Pioglit MF Forte (Pioglitazone 15 mg + Metformin 850 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Related Diabetes Medications<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/pioz-15\/\">Pioz 15 &mdash; Pioglitazone 15 mg monotherapy<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/glycomet-sr\/\">Glycomet SR &mdash; Metformin sustained-release<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/januvia\/\">Januvia &mdash; Sitagliptin (DPP-4 inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/jardiance-empagliflozin\/\">Jardiance &mdash; Empagliflozin (SGLT-2 inhibitor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/glisen-pm\/\">Glisen PM &mdash; Glimepiride + Pioglitazone + Metformin triple combo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/diabetes-medication\/\"><strong>Browse all Diabetes Medications<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0391\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u0395\u03c5\u03b8\u03cd\u03bd\u03b7\u03c2.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Pioglitazone-containing products are contraindicated in heart failure and active bladder cancer &mdash; always use under medical guidance with renal, liver, and cardiovascular monitoring.<\/div>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Manages blood sugar levels<br \/>\n\u2705 Combines two effective drugs<br \/>\n\u2705 Enhances glycemic control<br \/>\n\u2705 Reduces insulin resistance<br \/>\n\u2705 Improves overall diabetes management<\/h5>\n<p><span style=\"color: #999999;\">Pioglit Mf Forte contains Pioglitazone and Metformin<\/span><\/p>","protected":false},"featured_media":50754,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[],"class_list":{"0":"post-50753","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","11":"first","12":"outofstock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/50753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=50753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/50754"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=50753"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=50753"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=50753"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=50753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}